Astrazeneca (AZN) Goodwill & Intangibles (2009 - 2026)

Astrazeneca (AZN) has reported Goodwill & Intangibles for 18 consecutive years, with $58.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 0.99% year-over-year to $58.1 billion; the TTM figure through Mar 2026 stood at $58.1 billion (down 0.99% YoY), while the FY2025 annual figure was $59.1 billion, up 1.52% from the prior year.
• Goodwill & Intangibles came in at $58.1 billion for Q1 2026 at Astrazeneca, down from $59.1 billion in the prior quarter.
• The five-year high for Goodwill & Intangibles was $61.2 billion in Q1 2022, with the low at $2.4 billion in Q4 2023.
• Average Goodwill & Intangibles over 5 years is $55.8 billion, with a median of $59.1 billion recorded in 2022.
• Across the five-year window, Goodwill & Intangibles tumbled 95.95% in 2023 and jumped 2331.16% in 2024, its largest moves.
• Year by year, Goodwill & Intangibles stood at $59.1 billion in 2022, then sank by 95.95% to $2.4 billion in 2023, then surged by 2331.16% to $58.2 billion in 2024, then gained by 1.52% to $59.1 billion in 2025, then slipped by 1.67% to $58.1 billion in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $58.1 billion, $59.1 billion, and $59.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.